As molluscum is caused by a virus, it is highly contagious and can infect human tissue virtually anywhere on the body. Spread has been documented through the sharing of towels and bathing sponges, wrestling, and from a surgeon to several of his patients. This implies that direct human-to-human contact and contact with infected fomites are the most likely routes of transmission.
Conflicting reports make it unclear as to whether the disease may be spread by simple contact with seemingly intact lesions or if the breaking of a lesion and the subsequent transferring of core material is necessary for transmission. Secondary spread of lesions may occur by autoinoculation as well as by shaving and electrolysis. No known animal reservoir exists.
Swimming in public swimming pools has been implicated in molluscum transmission; however, studies have not provided sufficient epidemiologic evidence to confirm this association. These studies are speculative and the information given is anecdotal at best. Further evidence has linked swimming pool equipment such as the gymnasium bar and kick boards to the transference of molluscum contagiosum rather than the actual water itself.
Furthermore, the wet, warm climate in a swimming pool environment is believed to facilitate the spread of the virus by fomites. Steam baths, saunas, and communal spray baths have also been suspected as culprits in transmission. It is becoming increasingly more frequent as a sexually transmitted disease in sexually active young adults. This alarming fact makes an effective treatment for molluscum highly critical.
Because molluscum contagiosum is self-limited in healthy individuals, treatment may be unnecessary. Nonetheless, issues such as lesion visibility, underlying atopic disease, and the desire to prevent transmission may prompt therapy. Rapid treatment options include cryotherapy, curettage, and laser therapy. These options require a trained health care provider, may require local anesthesia, and can result in post-procedural pain, irritation, and scarring.
Gradual removal of lesions may be achieved by oral or topical therapy. These techniques are often desirable for pediatric patients because they are generally less painful and may be performed by parents at home in a less threatening environment. Oral cimetidine has been used as an alternative treatment for small children who are afraid of the pain associated with cryotherapy, curettage, and laser therapy. In addition, small children may not be cooperative with the application of topical therapy.
While cimetidine is safe, painless, and well tolerated, facial mollusca do not respond as well as lesions elsewhere on the body. Podophyllotoxin cream is reliable as a home therapy for men but is not recommended for pregnant women because of presumed toxicity to the fetus. Each lesion must be treated individually as the therapeutic effect is localized. Other options for topical therapy include iodine and salicylic acid, potassium hydroxide, tretinoin, cantharidin, and imiquimod. These treatments must be prescribed by a health care professional.
Most therapies are effective in immunocompetent patients; however, patients with HIV/AIDS or other immunosuppressed conditions often do not respond to traditional treatments. In addition, these treatments are largely ineffective in achieving long-term control in HIV patients.
AntiMolluscum-Rx is a potent yet safe anti-viral agent for topical use to eradicate molluscum infections. It quantifiably inhibits and kills the molluscum virus, resulting in fast elimination of molluscum; results are generally experienced in a matter of days. The Center for Biomedical Research conducted a peer review clinical trial of the antiviral extracts of AntiMolluscum-Rx against molluscum contagiosum.
As a result, AntiMolluscum-Rx is particularly invaluable not only in consideration of its ability to inactivate the extra cellular molluscum virus at very low concentrations, but also for its tolerability to healthy surrounding tissue, which makes this product so important in today's pharmacopia.
The ability of AntiMolluscum-Rx to eradicate molluscum contagiosum is not necessarily just a result of its antiviral nature, but also stems from its remarkable ability to penetrate into cell membranes do to its lipophilic character. The lipophilic tendency of the treatment allows it to penetrate into cell membranes to dissolve the lipo protein hull of the virus, thus destroying it.
It has the ability to dissolve molluscum because it contains protein dissolving enzymes. It can be stated that application of AntiMolluscum-Rx has an immediate therapeutic effect against Molluscum contagiosum and has a positive influence on the immune response. To learn more, please go to http://www.naturespharma.org.
Conflicting reports make it unclear as to whether the disease may be spread by simple contact with seemingly intact lesions or if the breaking of a lesion and the subsequent transferring of core material is necessary for transmission. Secondary spread of lesions may occur by autoinoculation as well as by shaving and electrolysis. No known animal reservoir exists.
Swimming in public swimming pools has been implicated in molluscum transmission; however, studies have not provided sufficient epidemiologic evidence to confirm this association. These studies are speculative and the information given is anecdotal at best. Further evidence has linked swimming pool equipment such as the gymnasium bar and kick boards to the transference of molluscum contagiosum rather than the actual water itself.
Furthermore, the wet, warm climate in a swimming pool environment is believed to facilitate the spread of the virus by fomites. Steam baths, saunas, and communal spray baths have also been suspected as culprits in transmission. It is becoming increasingly more frequent as a sexually transmitted disease in sexually active young adults. This alarming fact makes an effective treatment for molluscum highly critical.
Because molluscum contagiosum is self-limited in healthy individuals, treatment may be unnecessary. Nonetheless, issues such as lesion visibility, underlying atopic disease, and the desire to prevent transmission may prompt therapy. Rapid treatment options include cryotherapy, curettage, and laser therapy. These options require a trained health care provider, may require local anesthesia, and can result in post-procedural pain, irritation, and scarring.
Gradual removal of lesions may be achieved by oral or topical therapy. These techniques are often desirable for pediatric patients because they are generally less painful and may be performed by parents at home in a less threatening environment. Oral cimetidine has been used as an alternative treatment for small children who are afraid of the pain associated with cryotherapy, curettage, and laser therapy. In addition, small children may not be cooperative with the application of topical therapy.
While cimetidine is safe, painless, and well tolerated, facial mollusca do not respond as well as lesions elsewhere on the body. Podophyllotoxin cream is reliable as a home therapy for men but is not recommended for pregnant women because of presumed toxicity to the fetus. Each lesion must be treated individually as the therapeutic effect is localized. Other options for topical therapy include iodine and salicylic acid, potassium hydroxide, tretinoin, cantharidin, and imiquimod. These treatments must be prescribed by a health care professional.
Most therapies are effective in immunocompetent patients; however, patients with HIV/AIDS or other immunosuppressed conditions often do not respond to traditional treatments. In addition, these treatments are largely ineffective in achieving long-term control in HIV patients.
AntiMolluscum-Rx is a potent yet safe anti-viral agent for topical use to eradicate molluscum infections. It quantifiably inhibits and kills the molluscum virus, resulting in fast elimination of molluscum; results are generally experienced in a matter of days. The Center for Biomedical Research conducted a peer review clinical trial of the antiviral extracts of AntiMolluscum-Rx against molluscum contagiosum.
As a result, AntiMolluscum-Rx is particularly invaluable not only in consideration of its ability to inactivate the extra cellular molluscum virus at very low concentrations, but also for its tolerability to healthy surrounding tissue, which makes this product so important in today's pharmacopia.
The ability of AntiMolluscum-Rx to eradicate molluscum contagiosum is not necessarily just a result of its antiviral nature, but also stems from its remarkable ability to penetrate into cell membranes do to its lipophilic character. The lipophilic tendency of the treatment allows it to penetrate into cell membranes to dissolve the lipo protein hull of the virus, thus destroying it.
It has the ability to dissolve molluscum because it contains protein dissolving enzymes. It can be stated that application of AntiMolluscum-Rx has an immediate therapeutic effect against Molluscum contagiosum and has a positive influence on the immune response. To learn more, please go to http://www.naturespharma.org.
SHARE
